Anika Therapeutics, Inc.
ANIK
Revenue
41.92M
▲1.40M▲3.45%
3 Months ChangeAssets
262.66M
▼-1.09M▼-0.4129%
3 Months ChangeLiabilities
52.32M
▼-2.89M▼-5.24%
3 Months ChangeFree Cash Flow
-1.93M
▲3.07M▲61.37%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001171843-24-005923
2024-10-31
Form 8-K
ID: 0001171843-24-005922
2024-08-08
Form 10-Q
ID: 0001171843-24-004615
2024-08-08
Form 8-K
ID: 0001171843-24-004607
2024-07-11
Form 8-K
ID: 0001171843-24-003900
2024-05-28
Form 8-K
ID: 0001171843-24-003136
2024-05-08
Form 10-Q
ID: 0001171843-24-002682
2024-05-08
Form 8-K
ID: 0001171843-24-002673
2024-05-08
Form 8-K
ID: 0001171843-24-002672
2024-03-13
Form 8-K
ID: 0001171843-24-001322